Menu
  • The inaugural US E-Cigarette Summit was held in Washington DC, on Monday May 8, 2017 and welcomed over 250 people
  • The 2nd Annual US E-Cigarette Summit will take place April 30, 2018......Registration is now open

Dr. Nancy A. Rigotti

Professor of Medicine, Harvard Medical School
Director, Tobacco Research & Treatment Center, Massachusetts General Hospital, Boston

Nancy Rigotti, MD, is an internationally known expert in tobacco use, tobacco cessation, and tobacco control public policy. Trained as a general internist, she is Associate Chief of the Division of General Internal Medicine at Massachusetts General Hospital, a Professor of Medicine at Harvard Medical School, and Past President of both the Society of General Internal Medicine and the Society for Research in Nicotine and Tobacco. Dr. Rigotti founded and directs the Tobacco Research and Treatment Center at Massachusetts General Hospital. This program combines a clinical service (MGH Tobacco Treatment Smoking Service) with a multidisciplinary research group whose mission is to develop innovative and effective smoking cessation treatment and tobacco control policy approaches. Her research includes formal evaluations of the effects of tobacco control public policy and clinical and outcomes research studies testing behavioral and pharmacologic smoking cessation treatments. Her current research focuses on developing and testing systems that embed tobacco dependence treatment into the evolving U.S. health care delivery system, with a special interest in using hospitalization as an opportunity to promote tobacco cessation. With colleagues from the Tobacco Research and Treatment Center and DFHCC, Dr. Rigotti is also testing smoking cessation interventions targeting patients with cancer, peripheral vascular disease, parents of children attending pediatric practices, and patients in primary care practices.

Dr. Nancy A. Rigotti will be speaking at:

Discussion and Open Floor Q&A: How Can We Help the Public Understand Relative Risks?

- 12:10 - 12:40

The National Academies of Science, Engineering and Medicine Report on E-Cigarettes – Summary and Relevance to Clinicians

- 10:55 - 11:10

« Back to previous page